Jeff Cislini Revolution Medicines, Inc. (RVMD) insider trading activity

Jeff Cislini is General Counsel of Revolution Medicines, Inc.. Currently has a direct ownership of 43,080 shares of RVMD, which is worth approximately $2.48 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 2,554 shares (Common Stock) at a price of $55.13 per share, resulting in proceeds of $140,802. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.1K

8.51% 3M change

11.86% 12M change

Total Value Held $2.48 Million

Jeff Cislini Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2024	SELL Open market or private sale	$140,802 $55.13 p/Share	2,554 Reduced 5.6%	43,080 Common Stock
Nov 06 2024	SELL Open market or private sale	$360,000 $60.0 p/Share	6,000 Reduced 11.62%	45,634 Common Stock
Nov 06 2024	BUY Exercise of conversion of derivative security	$219,420 $36.57 p/Share	6,000 Added 10.41%	51,634 Common Stock
Oct 11 2024	SELL Open market or private sale	$301,020 $50.17 p/Share	6,000 Reduced 11.62%	45,634 Common Stock
Oct 11 2024	BUY Exercise of conversion of derivative security	$219,420 $36.57 p/Share	6,000 Added 10.41%	51,634 Common Stock
Sep 16 2024	SELL Open market or private sale	$64,252 $44.19 p/Share	1,454 Reduced 3.09%	45,634 Common Stock
Jul 09 2024	SELL Open market or private sale	$97,951 $40.83 p/Share	2,399 Reduced 4.85%	47,088 Common Stock
Jun 26 2024	SELL Open market or private sale	$76,940 $38.47 p/Share	2,000 Reduced 3.88%	49,487 Common Stock
Jun 17 2024	SELL Open market or private sale	$65,694 $37.39 p/Share	1,757 Reduced 3.3%	51,487 Common Stock
May 21 2024	SELL Open market or private sale	$58,635 $39.09 p/Share	1,500 Reduced 2.76%	52,874 Common Stock
Mar 27 2024	SELL Open market or private sale	$46,425 $30.95 p/Share	1,500 Reduced 2.68%	54,374 Common Stock
Mar 18 2024	SELL Open market or private sale	$39,538 $31.58 p/Share	1,252 Reduced 2.19%	55,874 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	21,000 Added 26.88%	57,126 Common Stock
Jan 22 2024	SELL Open market or private sale	$40,500 $27.0 p/Share	1,500 Reduced 3.99%	36,126 Common Stock
Dec 18 2023	SELL Open market or private sale	$31,831 $25.9 p/Share	1,229 Reduced 3.19%	37,284 Common Stock
Nov 20 2023	SELL Open market or private sale	$32,550 $21.7 p/Share	1,500 Reduced 3.75%	38,513 Common Stock
Sep 28 2023	SELL Open market or private sale	$57,160 $28.58 p/Share	2,000 Reduced 4.76%	40,013 Common Stock
Sep 18 2023	SELL Open market or private sale	$38,010 $31.31 p/Share	1,214 Reduced 2.81%	42,013 Common Stock
Jul 31 2023	SELL Open market or private sale	$39,030 $26.02 p/Share	1,500 Reduced 3.35%	43,227 Common Stock
Jun 20 2023	SELL Open market or private sale	$31,148 $25.14 p/Share	1,239 Reduced 2.7%	44,727 Common Stock

Jeff Cislini

General Counsel

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account